Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

TARZANA TREATMENT CENTERS, INC.

NPI: 1396076147 · TARZANA, CA 91356 · Federally Qualified Health Center (FQHC) · NPI assigned 01/19/2010

$9.73M
Total Medicaid Paid
126,840
Total Claims
88,392
Beneficiaries
59
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSENELLA, ALBERT (PRESIDENT/ CEO)
NPI Enumeration Date01/19/2010

Related Entities

Other providers sharing the same authorized official: SENELLA, ALBERT

ProviderCityStateTotal Paid
TARZANA TREATMENT CENTERS, INC. TARZANA CA $19.51M
TARZANA TREATMENT CENTERS, INC. PALMDALE CA $2.75M
TARZANA TREATMENT CENTERS, INC. LONG BEACH CA $677K
TARZANA TREATMENT CENTERS, INC WOODLAND HILLS CA $66K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,013 $1.11M
2019 718 $667K
2020 6,102 $1.39M
2021 22,854 $473K
2022 19,064 $1.07M
2023 39,554 $2.27M
2024 37,535 $2.75M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
T1015 Clinic visit/encounter, all-inclusive 24,657 19,820 $4.45M
J2315 Injection, naltrexone, depot form, 1 mg 2,600 2,394 $3.21M
G9012 Other specified case management service not elsewhere classified 36,166 17,942 $1.63M
H0043 Supported housing, per diem 1,378 809 $125K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3,504 3,175 $118K
G9008 Coordinated care fee, physician coordinated care oversight services 7,918 2,729 $47K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 6,554 5,618 $37K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 229 223 $32K
G9920 Screening performed and negative 835 818 $23K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6,449 5,388 $10K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,778 3,139 $8K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,551 1,343 $8K
99205 Prolong outpt/office vis 656 633 $6K
0051A 67 67 $4K
0124A 62 62 $4K
0134A 38 38 $3K
99215 Prolong outpt/office vis 1,727 1,582 $2K
0052A 16 16 $1K
0121A 16 16 $1K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3,092 2,690 $917.21
0011A 12 12 $804.00
99000 666 590 $713.79
99490 Ccm add 20min 43 39 $586.42
G9919 Screening performed and positive and provision of recommendations 17 14 $435.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 14 13 $308.14
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 299 258 $274.40
G0442 Annual alcohol misuse screening, 5 to 15 minutes 354 233 $193.05
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 33 19 $102.90
1126F 1,942 1,542 $0.00
3008F 1,380 1,298 $0.00
3079F 584 494 $0.00
2001F 1,382 1,301 $0.00
1000F 1,385 1,279 $0.00
3074F 1,300 984 $0.00
3080F 362 295 $0.00
2000F 1,381 1,299 $0.00
2010F 1,388 1,305 $0.00
3075F 252 177 $0.00
1170F 1,520 914 $0.00
1034F 463 441 $0.00
1036F 1,292 773 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 385 242 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 283 175 $0.00
1125F 541 327 $0.00
36415 Collection of venous blood by venipuncture 73 41 $0.00
3078F 1,039 734 $0.00
1159F 761 678 $0.00
4004F 789 768 $0.00
3077F 429 334 $0.00
1160F 1,868 1,244 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 860 524 $0.00
81003 340 213 $0.00
3288F 1,460 870 $0.00
1158F 188 131 $0.00
99173 272 167 $0.00
99442 37 35 $0.00
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 94 85 $0.00
99072 13 13 $0.00
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 46 29 $0.00